Acute ischemic stroke
Conditions
Interventions
Experimental group:Wenyang Tongluo Decoction
Control group:Warming Yang Tongluo placebo
Sponsors
Chongqing Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) meet the Western medicine diagnostic criteria for ischemic stroke and the Chinese medicine diagnostic criteria for stroke; (2) TCM syndrome differentiation is Yang deficiency syndrome; (3) Duration of onset =7 days; (4) 3 points =NIHSS=20 points; (5) Age =18 years old; (6) The patient or legal representative gives informed consent and signs the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients who have received or plan to undergo intravascular interventional therapy (including arteriovenous thrombolysis, bridging, mechanical thrombectomy, angioplasty, and stenting); (2) There are major underlying diseases, serious liver or renal insufficiency (ALT or AST > 80u/l; Serum creatinine > 266umol/l (male), serum creatinine > 212umol/l (female)); (3) People with other non-cerebrovascular diseases caused by limb movement dysfunction; (4) other diseases or mental disorders that the investigator believes may limit the evaluation of neurological function or affect patient follow-up; (5) Pregnant or lactating women; (6) Those who are participating in clinical trials of other drugs; (7) There are contraindications for the drug therapy used in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIHSS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| mRS;Barthel index;functional comprehensive assessment,FCA;TCM syndrome score; | — |
Countries
China
Contacts
Public ContactJun Tang
Chongqing Hospital of Traditional Chinese Medicine
Outcome results
None listed